Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04889742 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Study acronym: HETERERO
StatusNot Yet Recruiting
PhasePhase 2
Started2024-05-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 26, 2023 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2023-12-19
notable
Recruiting→Not Yet Recruiting Study Status, Sponsor/Collaborators, Contacts/Locations v1
Trial statusRecruiting→Not Yet Recruiting
Start date2021-05-10→2024-05-10
Study sitesdetails revised at 1 of 1 site
2021-05-12
minor
Original filing
2,904 trials monitored
See 127 trials at risk
2,471 trials monitored
See 156 trials at risk
1,634 trials monitored
See 90 trials at risk
and 3 more diseases
This study investiagates deep-regional or superficial hyperthermia to enhance radiotherapy or chemoradiation in patients that suffer recurrent disease after previous radiotherapy.
Trial Details
NCT Number NCT04889742
Lead Sponsor Charite University, Berlin, Germany
Conditions Recurrent Cancer, Prostate Cancer, Cervical Cancer, Anal Cancer, Sarcoma, Rectal Cancer, Neuroendocrine Tumors, Esophageal Cancer +2 more
Enrollment 110 participants
Start Date 2024-05-10
Primary Completion 2026-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2023-12-26